Akorn, Inc. (NASDAQ:AKRX)

CAPS Rating: 2 out of 5

The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.

AKRX News and Commentary

Caps

How do you think AKRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

201 Outperform
19 Underperform
 

All-Star Players

36 Outperform
5 Underperform
 

Wall Street

8 Outperform
0 Underperform
 

Top AKRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

HealthcareGuy (97.15)
Submitted December 29, 2010

Akorn, is a generic pharma company that has been remade by successful healthcare turnaround investor John Kapoor (Chariman of the Board). The major catalyst for this name, will be FDA approval of AKRX’s generic version of Vancocin (first to file,… More

OriginalBarnacle (89.75)
Submitted August 23, 2007

P/b = 10.2P/S = 12.7No earningsMargins are worse with increasing inventory.Price change over 106%

AKRX VS S&P 500 (SPY)

Fools bullish on AKRX are also bullish on:

Fools bearish on AKRX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AKRX.

Recs

0
Member Avatar LazyHarlequin (50.89) Submitted: 4/23/2018 1:40:44 PM : Underperform Start Price: $13.80 AKRX Score: -20.51

Stock dropped $4+ on 4/23/18 after Fresenius SE indicated it could turn its back on the planned acquisition of generic drug company Akorn Inc. if evidence of wrongdoing materializes, the German healthcare company's chief executive said. Fresenius said overnight it was investigating potential breaches of U.S. Food and Drug Administration data-integrity requirements on product development at Akorn

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/3/2017 3:52:12 PM : Outperform Start Price: $23.99 AKRX Score: -45.24

Wide range of generic drugs for human and animal use. Long history, global reach, improving profitability. Signs of bottoming out.

Recs

0
Member Avatar TerryHoodSr (56.53) Submitted: 5/6/2016 2:22:51 PM : Outperform Start Price: $20.10 AKRX Score: -50.53

Potential buying opportunity

Leaderboard

Find the members with the highest scoring picks in AKRX.

Score Leader

jkleiman

jkleiman (< 20) Score: +874.91

The Score Leader is the player with the highest score across all their picks in AKRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jkleiman < 20 11/10/2009 Outperform 5Y $1.53 +1,031.37% +156.46% +874.91 0 Comment
marksaal 49.17 10/19/2009 Outperform 3Y $1.55 +1,016.77% +155.03% +861.74 0 Comment
joker245 85.01 11/12/2009 Outperform 5Y $1.58 +995.57% +154.51% +841.06 0 Comment
LRiquel86 44.46 11/20/2009 Outperform 5Y $1.58 +995.57% +156.26% +839.31 0 Comment
Bonnell65 79.19 11/16/2009 Outperform 5Y $1.59 +988.68% +153.63% +835.05 0 Comment
CetiAlphaV 65.89 10/20/2009 Outperform 5Y $1.60 +981.88% +154.66% +827.21 0 Comment
terpgrad 75.42 11/11/2009 1/11/2017 Outperform 3Y $1.61 +975.16% +154.35% +820.81 0 Comment
MicroMikey 64.35 3/9/2010 Outperform 5Y $1.72 +906.40% +145.73% +760.67 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. STORMIN01 < 20 4/20/2010 Outperform 5Y $1.87 +825.67% +131.74% +693.93 0 Comment
Cruzera < 20 4/22/2010 Outperform 3M $2.05 +744.39% +133.67% +610.72 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackUltraLong < 20 5/3/2018 Outperform NS $11.40 +51.84% +7.14% +44.70 1 Comment
TrackJimCramer 85.60 3/24/2015 Outperform 3W $48.16 -64.06% +34.07% -98.12 0 Comment
TrackWallachBeth 53.30 10/14/2014 Outperform NS $34.11 -49.25% +48.58% -97.84 0 Comment
TrackRBCCapMkts 88.93 9/29/2014 Outperform NS $36.08 -52.02% +42.69% -94.71 0 Comment
TrackMerrill 91.54 9/27/2012 Outperform NS $13.10 +32.14% +94.57% -62.43 0 Comment
TrackTMFFoolish8 < 20 3/8/2012 Outperform 5Y $11.69 +16.94% +3.33% +13.60 8/31/2012 @ $13.67 0 Comment
TrackNeedham 92.61 1/18/2012 Outperform NS $10.88 +59.10% +116.50% -57.40 0 Comment
TrackDeutscheSec 87.41 9/16/2011 Outperform NS $9.03 +49.61% +11.08% +38.54 7/23/2012 @ $13.51 0 Comment
TrackRodmanRen < 20 7/15/2010 Outperform NS $3.19 +442.63% +155.41% +287.22 0 Comment
TrackCreditSuiss 89.04 2/26/2009 Outperform NS $1.97 +778.68% +266.24% +512.44 0 Comment
TrackFBRCapitalM 88.47 10/13/2006 Outperform NS $4.09 +61.86% -2.25% +64.11 2/8/2008 @ $6.62 0 Comment

Featured Broker Partners


Advertisement